GSK: latest news, analysis and trading updates | ESM Magazine

GSK Rejects Elliott's Demands For Board, Consumer Business

GSK's board on Friday rejected Elliott's demands that the British company change its board and sell its consumer healthcare arm after separating it from it...

GSK Unveils Plan For Consumer Healthcare Unit

Britain's GSK has unveiled a detailed plan to spin off its consumer healthcare venture with Pfizer into a separate company by the middle of next...

GSK To Boost Spending Power Of Pharma Business Post Break-up

GlaxoSmithKline will lay out plans to boost the spending power of its research-focused pharmaceuticals business at an investor day on Wednesday, as analyst...

Public And Private Sectors Launch Coalition To Protect Tropical Forests

A new public-private coalition was launched at The Leaders Summit on Climate, aiming to raise more than $1 billion to finance initiatives on prot...

GSK Sees Lower Profit This Year As COVID-19 Disruptions Drag On

GSK warned of a bigger than expected fall in earnings this year as the COVID-19 pandemic continues to disrupt other healthcare treatments and the British d...

GSK Profit Misses Expectations As Vaccine Sales Disappoint, Stockpiling Eases

Britain's GSK fell short of quarterly expectations for profit on Wednesday, as sales of its existing vaccines fell and stockpiling of pain and lung medicat...

GSK, Philip Morris Venture Tie-Up For Potential COVID-19 Shot

GSK, the world's largest vaccine maker, on Tuesday announced the latest partnership for its vaccine booster technology to develop and test a potential COVI...

GSK Aims For 1bn Doses Of Booster As COVID-19 Vaccine Race Heats Up

GSK, the world's largest vaccine maker has laid out plans to produce 1 billion doses of vaccine efficacy boosters for COVID-19 shots next year, as the race...